Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) reached a new 52-week high on Friday. The stock traded as high as $51.10 and last traded at $51.10, with a volume of 344 shares. The stock had previously closed at $45.90.
Orion OYJ Trading Up 9.5%
The company has a market cap of $14.42 billion, a PE ratio of 21.03 and a beta of 0.07. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The company has a 50 day simple moving average of $45.80 and a two-hundred day simple moving average of $41.39.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last released its earnings results on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%. The company had revenue of $606.38 million during the quarter.
About Orion OYJ
Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.
The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas.
Featured Articles
- Five stocks we like better than Orion OYJ
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
